XML 41 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Pay vs Performance Disclosure
12 Months Ended
Jan. 01, 2023
USD ($)
Jan. 02, 2022
USD ($)
Jan. 03, 2021
USD ($)
Pay vs Performance Disclosure [Table]      
Pay vs Performance [Table Text Block]
Pay versus Performanc
e
In accordance with rules adopted by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide the following disclosure regarding executive compensation for our principal executive officer (“PEO”) and
Non-PEO
NEOs and Company performance for the fiscal years listed below. For further information concerning Illumina’s pay for performance philosophy and how Illumina aligns executive compensation with the Company’s performance, refer to “Compensation Discussion and Analysis”.
 
Year
 
Summary
Compensation
Table Total
for PEO¹

($)
 
Compensation
Actually Paid
to PEO
1,2,3

($)
 
Average
Summary
Compensation
Table Total for
Non-PEO

NEOs
1

($)
 
Average
Compensation
Actually Paid
to
Non-PEO

NEOs
1,2,3

($)
 
Value of Initial
Fixed $100
Investment
based on:
4
 
Net Income
($ Millions)
 
Core
Illumina
Revenue
5
 
TSR
($)
 
Peer
Group
TSR
($)
                 
2022
  26,752,197   (10,053,847)   5,772,066   (3,358,918)   60.85   112.78   (4,404)   4,553
                 
2021
  14,333,634   36,737,462   8,019,825   8,297,373   114.49   125.49   762   4,519
                 
2020
  11,733,593   (208,167)   3,571,019   540,066   111.35   125.46   656   3,239
 
  1.
Francis deSouza was our PEO for each year presented. The individuals comprising the
Non-PEO
NEOs for each year presented are
as
follows:
 
 
   
2022: Messrs. Samad and Goswami, Ms. Tousi, and Drs. Aravanis and Febbo served as
Non-PEO
NEOs.
 
 
   
2021: Robert Ragusa, Charles Dadswell, Mr. Samad, Ms. Tousi, and Dr. Aravanis served as
Non-PEO
NEOs.
 
 
   
2020: Mark Van Oene, Mr. Samad, Ms. Tousi, and Dr. Aravanis served as
Non-PEO
NEOs.
 
 
  2.
The amounts shown for Compensation Actually Paid have been calculated in accordance with Item 402(v) o
f
Regulation
S-K
and do not reflect compensation actually earned, realized, or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as
described
in footnote 3 below.
 
 
  3.
Compensation Actually Paid reflects the exclusions and inclusions of certain amounts for the PEO and the
Non-PEO
NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718. Amounts in the Exclusion of Stock Awards column are the totals from the Stock Awards column set forth in the Summary Compensation Table.
 
 
Year
  
Summary
Compensation Table
Total for PEO

($)
  
Exclusion of Equity Awards
Reported in the Summary
Compensation Table for PEO

($)
  
Inclusion of Equity
Values for PEO

($)
  
Compensation
Actually Paid to PEO

($)
         
2022
   26,752,197    (25,000,304)    (11,805,740)    (10,053,847)
         
2021
   14,333,634    (11,000,700)    33,404,528    36,737,462
         
2020
   11,733,593    (10,000,153)    (1,941,607)    (208,167)
 
Year
  
Average Summary
Compensation Table
Total for
Non-PEO

NEOs
($)
  
Average Exclusion of Equity
Awards Reported in the
Summary Compensation
Table for
Non-PEO
NEOs
($)
  
Average Inclusion of
Equity Values for Non-

PEO NEOs
($)
  
Average
Compensation
Actually Paid to Non-

PEO NEOs
($)
         
2022
   5,772,066    (5,100,400)    (4,030,584)    (3,358,918)
         
2021
   8,019,825    (6,360,445)    6,637,993    8,297,373
         
2020
   3,571,019    (2,937,682)    (93,271)    540,066
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
 
Year
  
Year-End Fair

Value of
Equity Awards
Granted
During Year
That
Remained
Unvested as
of Last Day of
Year for PEO
($)
  
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
PEO
($)
  
Vesting-Date

Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for PEO
($)
  
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards that
Vested
During Year
for PEO
($)
  
Fair Value at
Last Day of
Prior Year of
Equity
Awards
Forfeited
During Year
for PEO
($)
  
Value of
Dividends or
Other
Earnings
Paid on
Stock or
Option
Awards Not
Otherwise
Included for
PEO
($)
  
Total -

Inclusion of
Equity
Values for
PEO
($)
2022
   5,893,604    (9,755,210)       (7,944,134)          (11,805,740)
2021
   13,252,665    11,935,271    623,638    7,592,954          33,404,528
2020
   2,309,910    (4,824,962)    648,689    (75,244)          (1,941,607)
 
Year
  
Average Year-

End Fair
Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day of
Year for
Non-

PEO NEOs
($)
  
Average
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
Non-PEO

NEOs
($)
  
Average
Vesting-Date

Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Non-PEO

NEOs
($)
  
Average
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards that
Vested
During Year
for Non-

PEO NEOs
($)
  
Average
Fair Value at
Last Day of
Prior Year
of Equity
Awards
Forfeited
During Year
for
Non-

PEO NEOs
($)
  
Average Value
of Dividends
or Other
Earnings Paid
on Stock or
Option
Awards Not
Otherwise
Included for
Non-PEO

NEOs
($)
  
Total -
Average
Inclusion
of
Equity
Values for
Non-PEO

NEOs
($)
2022
   909,353    (2,318,623)    57,391    (1,580,261)    (1,098,444)       (4,030,584)
2021
   3,111,992    2,503,161    146,440    1,086,930    (210,530)       6,637,993
2020
   694,398    (882,612)    109,648    (14,705)          (93,271)
 
  4.
The Peer Group TSR set forth in this table utilizes the NASDAQ Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation
S-K
included in our Annual Report for the year ended January 1, 2023. The comparison assumes $100 was invested for the period starting December 30, 2019, through the end of the listed year in the Company and in the NASDAQ Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
 
 
  5.
We determined Core Illumina Revenue to be the most important financial performance measure us
e
d to link Compa
ny
performance to Compensation Actually Paid to our PEO and
Non-PEO
N
EO
s in 2022. This performance measure may not have been the most important financial performance measure for years 2021 and 2020 and we may determine a different financial performance measure to be the most important financial performance measure in future years.
 
   
Company Selected Measure Name Core Illumina Revenue    
Named Executive Officers, Footnote [Text Block]
 
  1.
Francis deSouza was our PEO for each year presented. The individuals comprising the
Non-PEO
NEOs for each year presented are
as
follows:
 
 
   
2022: Messrs. Samad and Goswami, Ms. Tousi, and Drs. Aravanis and Febbo served as
Non-PEO
NEOs.
 
 
   
2021: Robert Ragusa, Charles Dadswell, Mr. Samad, Ms. Tousi, and Dr. Aravanis served as
Non-PEO
NEOs.
 
 
   
2020: Mark Van Oene, Mr. Samad, Ms. Tousi, and Dr. Aravanis served as
Non-PEO
NEOs.
 
 
   
Peer Group Issuers, Footnote [Text Block]
The Peer Group TSR set forth in this table utilizes the NASDAQ Biotechnology Index, which we also utilize in the stock performance graph required by Item 201(e) of Regulation
S-K
included in our Annual Report for the year ended January 1, 2023. The comparison assumes $100 was invested for the period starting December 30, 2019, through the end of the listed year in the Company and in the NASDAQ Biotechnology Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.
   
PEO Total Compensation Amount $ 26,752,197 $ 14,333,634 $ 11,733,593
PEO Actually Paid Compensation Amount $ (10,053,847) 36,737,462 (208,167)
Adjustment To PEO Compensation, Footnote [Text Block]
 
Year
  
Summary
Compensation Table
Total for PEO

($)
  
Exclusion of Equity Awards
Reported in the Summary
Compensation Table for PEO

($)
  
Inclusion of Equity
Values for PEO

($)
  
Compensation
Actually Paid to PEO

($)
         
2022
   26,752,197    (25,000,304)    (11,805,740)    (10,053,847)
         
2021
   14,333,634    (11,000,700)    33,404,528    36,737,462
         
2020
   11,733,593    (10,000,153)    (1,941,607)    (208,167)
 
The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:
 
Year
  
Year-End Fair

Value of
Equity Awards
Granted
During Year
That
Remained
Unvested as
of Last Day of
Year for PEO
($)
  
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
PEO
($)
  
Vesting-Date

Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for PEO
($)
  
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards that
Vested
During Year
for PEO
($)
  
Fair Value at
Last Day of
Prior Year of
Equity
Awards
Forfeited
During Year
for PEO
($)
  
Value of
Dividends or
Other
Earnings
Paid on
Stock or
Option
Awards Not
Otherwise
Included for
PEO
($)
  
Total -

Inclusion of
Equity
Values for
PEO
($)
2022
   5,893,604    (9,755,210)       (7,944,134)          (11,805,740)
2021
   13,252,665    11,935,271    623,638    7,592,954          33,404,528
2020
   2,309,910    (4,824,962)    648,689    (75,244)          (1,941,607)
   
Non-PEO NEO Average Total Compensation Amount $ 5,772,066 8,019,825 3,571,019
Non-PEO NEO Average Compensation Actually Paid Amount $ (3,358,918) 8,297,373 540,066
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Year
  
Average Summary
Compensation Table
Total for
Non-PEO

NEOs
($)
  
Average Exclusion of Equity
Awards Reported in the
Summary Compensation
Table for
Non-PEO
NEOs
($)
  
Average Inclusion of
Equity Values for Non-

PEO NEOs
($)
  
Average
Compensation
Actually Paid to Non-

PEO NEOs
($)
         
2022
   5,772,066    (5,100,400)    (4,030,584)    (3,358,918)
         
2021
   8,019,825    (6,360,445)    6,637,993    8,297,373
         
2020
   3,571,019    (2,937,682)    (93,271)    540,066
 
Year
  
Average Year-

End Fair
Value of
Equity
Awards
Granted
During Year
That
Remained
Unvested as
of Last Day of
Year for
Non-

PEO NEOs
($)
  
Average
Change in
Fair Value
from Last
Day of Prior
Year to Last
Day of Year
of Unvested
Equity
Awards for
Non-PEO

NEOs
($)
  
Average
Vesting-Date

Fair Value of
Equity
Awards
Granted
During Year
that Vested
During Year
for Non-PEO

NEOs
($)
  
Average
Change in
Fair Value
from Last
Day of Prior
Year to
Vesting
Date of
Unvested
Equity
Awards that
Vested
During Year
for Non-

PEO NEOs
($)
  
Average
Fair Value at
Last Day of
Prior Year
of Equity
Awards
Forfeited
During Year
for
Non-

PEO NEOs
($)
  
Average Value
of Dividends
or Other
Earnings Paid
on Stock or
Option
Awards Not
Otherwise
Included for
Non-PEO

NEOs
($)
  
Total -
Average
Inclusion
of
Equity
Values for
Non-PEO

NEOs
($)
2022
   909,353    (2,318,623)    57,391    (1,580,261)    (1,098,444)       (4,030,584)
2021
   3,111,992    2,503,161    146,440    1,086,930    (210,530)       6,637,993
2020
   694,398    (882,612)    109,648    (14,705)          (93,271)
   
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Over the three-year period from 2020 to 2022, our TSR trended in a manner similar to the Peer Group TS
R
. The increase in the Company’s TSR lagged our peers in 2020, and in 2021 our TSR showed a modest increase while the Peer Group TSR remained relatively flat. Our 2022 TSR performance was lower than that of our peers, which contributed to a significant decrease in “Compensation Actually Paid” to our CEO and NEOs in 2022. For 2020 to 2021, our TSR and net income showed a slight positive correlation to “Compensation Actually Paid”, which showed a larger increase because of the improvement in our financial outlook that drove a large increase in the yearend fair value of our PSUs. For 2021 to 2022, our TSR and net income showed a strong positive correlation to “Compensation Actually Paid” due to our emphasis on performance-based pay that ties our executive’s compensation to our stock price and financial performance. For 2020 to 2021, Core Illumina Revenue showed a positive correlation to “Compensation Actually Paid”,
but
an inverse correlation
for
2021 to 2022.
   
Compensation Actually Paid vs. Net Income [Text Block]
Over the three-year period from 2020 to 2022, our TSR trended in a manner similar to the Peer Group TS
R
. The increase in the Company’s TSR lagged our peers in 2020, and in 2021 our TSR showed a modest increase while the Peer Group TSR remained relatively flat. Our 2022 TSR performance was lower than that of our peers, which contributed to a significant decrease in “Compensation Actually Paid” to our CEO and NEOs in 2022. For 2020 to 2021, our TSR and net income showed a slight positive correlation to “Compensation Actually Paid”, which showed a larger increase because of the improvement in our financial outlook that drove a large increase in the yearend fair value of our PSUs. For 2021 to 2022, our TSR and net income showed a strong positive correlation to “Compensation Actually Paid” due to our emphasis on performance-based pay that ties our executive’s compensation to our stock price and financial performance. For 2020 to 2021, Core Illumina Revenue showed a positive correlation to “Compensation Actually Paid”,
but
an inverse correlation
for
2021 to 2022.
   
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Over the three-year period from 2020 to 2022, our TSR trended in a manner similar to the Peer Group TS
R
. The increase in the Company’s TSR lagged our peers in 2020, and in 2021 our TSR showed a modest increase while the Peer Group TSR remained relatively flat. Our 2022 TSR performance was lower than that of our peers, which contributed to a significant decrease in “Compensation Actually Paid” to our CEO and NEOs in 2022. For 2020 to 2021, our TSR and net income showed a slight positive correlation to “Compensation Actually Paid”, which showed a larger increase because of the improvement in our financial outlook that drove a large increase in the yearend fair value of our PSUs. For 2021 to 2022, our TSR and net income showed a strong positive correlation to “Compensation Actually Paid” due to our emphasis on performance-based pay that ties our executive’s compensation to our stock price and financial performance. For 2020 to 2021, Core Illumina Revenue showed a positive correlation to “Compensation Actually Paid”,
but
an inverse correlation
for
2021 to 2022.
   
Total Shareholder Return Vs Peer Group [Text Block]
Over the three-year period from 2020 to 2022, our TSR trended in a manner similar to the Peer Group TS
R
. The increase in the Company’s TSR lagged our peers in 2020, and in 2021 our TSR showed a modest increase while the Peer Group TSR remained relatively flat. Our 2022 TSR performance was lower than that of our peers, which contributed to a significant decrease in “Compensation Actually Paid” to our CEO and NEOs in 2022. For 2020 to 2021, our TSR and net income showed a slight positive correlation to “Compensation Actually Paid”, which showed a larger increase because of the improvement in our financial outlook that drove a large increase in the yearend fair value of our PSUs. For 2021 to 2022, our TSR and net income showed a strong positive correlation to “Compensation Actually Paid” due to our emphasis on performance-based pay that ties our executive’s compensation to our stock price and financial performance. For 2020 to 2021, Core Illumina Revenue showed a positive correlation to “Compensation Actually Paid”,
but
an inverse correlation
for
2021 to 2022.
   
Tabular List [Table Text Block]
 
    Financial Performance Measures    
Core Illumina Revenue
Earnings Per Share
Non-GAAP
Operating Income
 
   
Total Shareholder Return Amount $ 60.85 114.49 111.35
Peer Group Total Shareholder Return Amount 112.78 125.49 125.46
Net Income (Loss) $ (4,404,000,000) $ 762,000,000 $ 656,000,000
Company Selected Measure Amount 4,553 4,519 3,239
PEO Name Francis deSouza    
Measure [Axis]: 1      
Pay vs Performance Disclosure [Table]      
Measure Name Core Illumina Revenue    
Measure [Axis]: 2      
Pay vs Performance Disclosure [Table]      
Measure Name Earnings Per Share    
Measure [Axis]: 3      
Pay vs Performance Disclosure [Table]      
Measure Name Non-GAAP Operating Income    
PEO [Member] | Exclusion of Equity Awards Reported in the Summary Compensation [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ (25,000,304) $ (11,000,700) $ (10,000,153)
PEO [Member] | Inclusion of Equity Values for [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (11,805,740) 33,404,528 (1,941,607)
PEO [Member] | Year End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 5,893,604 13,252,665 2,309,910
PEO [Member] | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (9,755,210) 11,935,271 (4,824,962)
PEO [Member] | Vesting Date Fair Value of Equity Awards Granted During Year that Vested During [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 623,638 648,689
PEO [Member] | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (7,944,134) 7,592,954 (75,244)
PEO [Member] | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
PEO [Member] | Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 0 0 0
Non-PEO NEO [Member] | Exclusion of Equity Awards Reported in the Summary Compensation [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (5,100,400) (6,360,445) (2,937,682)
Non-PEO NEO [Member] | Inclusion of Equity Values for [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (4,030,584) 6,637,993 (93,271)
Non-PEO NEO [Member] | Year End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 909,353 3,111,992 694,398
Non-PEO NEO [Member] | Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (2,318,623) 2,503,161 (882,612)
Non-PEO NEO [Member] | Vesting Date Fair Value of Equity Awards Granted During Year that Vested During [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount 57,391 146,440 109,648
Non-PEO NEO [Member] | Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (1,580,261) 1,086,930 (14,705)
Non-PEO NEO [Member] | Fair Value at Last Day of Prior Year of Equity Awards Forfeited During Year [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount (1,098,444) (210,530) 0
Non-PEO NEO [Member] | Value of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise [Member]      
Pay vs Performance Disclosure [Table]      
Adjustment to Compensation Amount $ 0 $ 0 $ 0